Atea Pharmaceuticals, Inc. (AVIR) vs Orthofix Medical Inc. (OFIX)
A side-by-side comparison of Atea Pharmaceuticals, Inc. and Orthofix Medical Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AVIR
Atea Pharmaceuticals, Inc.
$5.19HealthcareDelayed quote: Oct 6, 2026, 11:30 AM EDT
OFIX
Orthofix Medical Inc.
$9.48HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — AVIR vs OFIX
growth of $100 · dividends reinvested · last 6yAVIR -83.1% (-25.6%/yr)OFIX -70.3% (-18.3%/yr)OFIX compounded faster over this window
AVIR OFIX
AVIR vs OFIX: by the numbers
- •AVIR is the larger company ($415M vs $383M market cap).
- •Both run net losses; AVIR's is the smaller (0.00% vs -7.41% net margin).
Metrics side by side
Valuation
| Metric | AVIR | OFIX |
|---|---|---|
| P/S ratio | N/A | 0.46 |
| P/B ratio | 2.03 | 0.89 |
| EV / EBITDA | N/A | 4.30 |
Profitability
| Metric | AVIR | OFIX |
|---|---|---|
| Gross margin | 0.00% | 69.59% |
| Operating margin | 0.00% | -3.05% |
| Net margin | 0.00% | -7.41% |
| ROE | -80.96% | -14.38% |
| ROIC | -89.93% | -3.55% |
Growth (annualized)
| Metric | AVIR | OFIX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.83% |
| Total return CAGR (5Y) | -34.44% | -23.97% |
Frequently asked
- How have AVIR and OFIX total returns compared?
- Over the past 5 years, AVIR delivered -34.44% and OFIX delivered -23.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.